BSX Operating Cash Flow (Statement)

Boston Scientific · Operating Cash Flow (Statement)

BSX logo

BSX Operating Cash Flow (Statement)

Latest reported$1.47B
BSX Quarterly Cash from Operations ($11.40M → $1.47B)
High-resolution chart · PNG

BSX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
1,474,000,000
348,000,000
1,364,000,000
1,343,000,000
1,286,000,000
541,000,000
1,456,000,000
1,002,000,000
813,000,000
164,000,000
957,000,000
698,000,000
658,000,000
190,000,000
807,000,000
471,000,000
306,000,000
-58,000,000
478,000,000
465,000,000
643,000,000
284,000,000
673,000,000
643,000,000
269,000,000
-77,000,000
692,000,000
502,000,000
292,000,000
350,000,000
19,000,000
501,000,000
-403,000,000
193,000,000
872,000,000
452,000,000
297,000,000
-7,000,000
466,000,000
-31,000,000
421,000,000
116,000,000
329,000,000
408,000,000
60,000,000
-197,000,000
440,000,000
346,000,000
285,000,000
198,000,000
273,000,000
251,000,000
397,000,000
187,000,000
369,000,000
272,000,000
407,000,000
212,000,000
349,000,000
366,000,000
390,000,000
-97,000,000
449,000,000
-126,000,000
286,000,000
-284,000,000
-329,000,000
484,000,000
419,000,000
261,000,000
54,000,000
638,000,000
258,000,000
266,000,000
308,000,000
474,000,000
211,000,000
-59,000,000
365,000,000
481,000,000
435,000,000
564,000,000
510,000,000
-287,000,000
239,000,000
441,000,000
657,000,000
573,000,000
532,000,000
42,000,000
234,000,000
199,000,000
245,000,000
109,000,000
196,000,000
322,000,000
159,000,000
59,000,000
162,000,000
114,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.